XML 59 R44.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidating Financial Information (Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
3 Months Ended
May 04, 2019
May 05, 2018
Cash flows from operating activities:    
Net income (loss) $ 136 $ 131
Equity in earnings of subsidiaries 0 0
Impairment and other costs 1 19
Dividends received from subsidiaries 0 0
Depreciation and amortization 236 235
Gains on sale of real estate (43) (24)
Change in assets, liabilities and other items not separately identified (368) (39)
Net cash provided (used) by operating activities (38) 322
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net (230) (167)
Other, net (7) 11
Net cash used by investing activities (237) (156)
Cash flows from financing activities:    
Debt repaid (3) (3)
Dividends paid (116) (116)
Issuance of common stock 6 28
Proceeds from noncontrolling interest 0 2
Intercompany activity, net 0 0
Other, net (45) (10)
Net cash used by financing activities (158) (99)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (433) 67
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 1,248 1,513
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 815 1,580
Parent    
Cash flows from operating activities:    
Net income (loss) 136 139
Equity in earnings of subsidiaries (132) (136)
Impairment and other costs 0 0
Dividends received from subsidiaries 225 200
Depreciation and amortization 0 0
Gains on sale of real estate 0 0
Change in assets, liabilities and other items not separately identified 78 150
Net cash provided (used) by operating activities 307 353
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net 0 0
Other, net 0 0
Net cash used by investing activities 0 0
Cash flows from financing activities:    
Debt repaid 0 0
Dividends paid (116) (116)
Issuance of common stock 6 28
Proceeds from noncontrolling interest   0
Intercompany activity, net (700) (254)
Other, net (93) (50)
Net cash used by financing activities (903) (392)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect (596) (39)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 889 1,109
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 293 1,070
Subsidiary Issuer    
Cash flows from operating activities:    
Net income (loss) (43) (69)
Equity in earnings of subsidiaries 30 (102)
Impairment and other costs 0 0
Dividends received from subsidiaries 0 0
Depreciation and amortization 85 82
Gains on sale of real estate (24) (23)
Change in assets, liabilities and other items not separately identified (118) 175
Net cash provided (used) by operating activities (70) 63
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net (52) (50)
Other, net 0 (10)
Net cash used by investing activities (52) (60)
Cash flows from financing activities:    
Debt repaid (3) (3)
Dividends paid 0 0
Issuance of common stock 0 0
Proceeds from noncontrolling interest   0
Intercompany activity, net 214 (10)
Other, net 28 23
Net cash used by financing activities 239 10
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 117 13
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 64 79
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 181 92
Other Subsidiaries    
Cash flows from operating activities:    
Net income (loss) 145 299
Equity in earnings of subsidiaries 0 0
Impairment and other costs 1 19
Dividends received from subsidiaries 0 0
Depreciation and amortization 151 153
Gains on sale of real estate (19) (1)
Change in assets, liabilities and other items not separately identified (328) (364)
Net cash provided (used) by operating activities (50) 106
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net (178) (117)
Other, net (7) 21
Net cash used by investing activities (185) (96)
Cash flows from financing activities:    
Debt repaid 0 0
Dividends paid (225) (200)
Issuance of common stock 0 0
Proceeds from noncontrolling interest   2
Intercompany activity, net 486 264
Other, net 20 17
Net cash used by financing activities 281 83
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 46 93
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 295 325
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period 341 418
Consolidating Adjustments    
Cash flows from operating activities:    
Net income (loss) (102) (238)
Equity in earnings of subsidiaries 102 238
Impairment and other costs 0 0
Dividends received from subsidiaries (225) (200)
Depreciation and amortization 0 0
Gains on sale of real estate 0 0
Change in assets, liabilities and other items not separately identified 0 0
Net cash provided (used) by operating activities (225) (200)
Cash flows from investing activities:    
Purchase of property and equipment and capitalized software, net 0 0
Other, net 0 0
Net cash used by investing activities 0 0
Cash flows from financing activities:    
Debt repaid 0 0
Dividends paid 225 200
Issuance of common stock 0 0
Proceeds from noncontrolling interest   0
Intercompany activity, net 0 0
Other, net 0 0
Net cash used by financing activities 225 200
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, beginning of period 0 0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, end of period $ 0 $ 0